UBS Asset Management Americas Inc. cut its stake in Validus Holdings, Ltd. (NYSE:VR) by 0.9% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 91,002 shares of the insurance provider’s stock after selling 833 shares during the quarter. UBS Asset Management Americas Inc. owned about 0.11% of Validus worth $4,270,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently made changes to their positions in VR. Boston Partners grew its position in Validus by 1,009.9% during the fourth quarter. Boston Partners now owns 4,279,398 shares of the insurance provider’s stock worth $200,789,000 after buying an additional 3,893,816 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC purchased a new position in Validus during the third quarter worth about $78,510,000. Victory Capital Management Inc. grew its position in Validus by 73.0% during the fourth quarter. Victory Capital Management Inc. now owns 1,985,484 shares of the insurance provider’s stock worth $93,159,000 after buying an additional 837,887 shares in the last quarter. Schroder Investment Management Group grew its position in Validus by 13.7% during the third quarter. Schroder Investment Management Group now owns 1,831,428 shares of the insurance provider’s stock worth $88,440,000 after buying an additional 220,900 shares in the last quarter. Finally, Cambiar Investors LLC purchased a new position in Validus during the third quarter worth about $10,810,000. Institutional investors own 98.97% of the company’s stock.
In other news, President Kean Driscoll sold 6,875 shares of the company’s stock in a transaction dated Tuesday, January 16th. The stock was sold at an average price of $46.78, for a total value of $321,612.50. Following the completion of the transaction, the president now directly owns 103,983 shares in the company, valued at approximately $4,864,324.74. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders sold a total of 20,625 shares of company stock valued at $1,102,544 over the last quarter. Company insiders own 2.33% of the company’s stock.
Validus (NYSE:VR) last posted its quarterly earnings data on Thursday, February 1st. The insurance provider reported $0.05 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.05 by ($1.00). Validus had a negative return on equity of 1.85% and a negative net margin of 1.70%. The firm had revenue of $346.88 million during the quarter, compared to analysts’ expectations of $352.00 million. During the same quarter in the previous year, the company posted $0.80 earnings per share. Validus’s revenue for the quarter was up 16.1% compared to the same quarter last year. research analysts anticipate that Validus Holdings, Ltd. will post 4.2 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 29th. Stockholders of record on Thursday, March 15th will be issued a $0.38 dividend. This represents a $1.52 dividend on an annualized basis and a dividend yield of 2.24%. The ex-dividend date of this dividend is Wednesday, March 14th. Validus’s payout ratio is currently -176.74%.
Several research firms recently commented on VR. Keefe, Bruyette & Woods upgraded Validus from a “market perform” rating to an “outperform” rating in a research report on Thursday, January 4th. Barclays restated a “hold” rating and set a $50.00 target price on shares of Validus in a research report on Tuesday, January 9th. Buckingham Research cut Validus from a “buy” rating to a “neutral” rating in a research report on Tuesday, February 13th. JMP Securities cut Validus from an “outperform” rating to a “market perform” rating in a research report on Tuesday, January 30th. Finally, Zacks Investment Research cut Validus from a “hold” rating to a “sell” rating in a research report on Saturday, January 13th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has issued a buy rating to the company’s stock. Validus currently has an average rating of “Hold” and an average target price of $52.80.
TRADEMARK VIOLATION WARNING: This news story was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this news story on another website, it was copied illegally and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2018/03/14/ubs-asset-management-americas-inc-sells-833-shares-of-validus-holdings-ltd-vr.html.
Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.
Receive News & Ratings for Validus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus and related companies with MarketBeat.com's FREE daily email newsletter.